Atlas Trials

Sequential and Personalized PK-guided Busulfan Administration in the Frame of the Conditiong Regimen for Allo-HSCT in Patients With Malignant Hemopathies Ineligible for the Standard Myeloablative Conditioning

Clinical trial NCT04451200 · NOT_YET_RECRUITING

Trial details

NCT number
NCT04451200
Sponsor
Institut Paoli-Calmettes
Status
NOT_YET_RECRUITING
Phase
Phase 2
Study type
INTERVENTIONAL
Acute LeukemiaMielodysplasic SyndromeMyeloproliferative Neoplasm
Start date
2020-11-01
Primary completion
2023-11-01
Enrollment
82

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.